Clinical Trial

Skin Involvement in Dupuytren Surgical Treatment Outcome

Study acronym: Skin in DD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Palmar skin is often retracted in Dupuytren disease (DD), making surgical management challenging and skin-preserving surgery difficult. Based on clinical experience in DD surgery and outcome, it is suspected that recurrence may be associated with such retracted skin. Possibly, this is due to presence and persistence of aligned myofibroblasts (MF), fixed to the deepest dermal layers. This interventional study aims to investigate the pathophysiological involvement of palmar skin in Dupuytren disease, and its implications for prognostics and treatment.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-11
Trial Details
NCT Number NCT07470684
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Conditions Dupuytren Disease
Enrollment 50 participants
Start Date 2024-12-10
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-10